Injectable Vitamin Product Recalled Due to Cold Chain Failure
Infuvite Adult injectable vitamins distributed to medical facilities in Mississippi and Florida are being recalled due to shipping delays during severe thunderstorms that may have compromised storage conditions and product potency.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for an injectable pharmaceutical product with a confirmed cold chain failure. Although no illnesses have been reported, the potential for compromised potency and quality meets the criterion of risk-of-harm products where injury has not yet been reported.
Plain-English summary
Infuvite Adult multiple vitamins injection has been recalled by Mckesson Medical-Surgical Inc. Affected lots are AA2279 (expiring 8/31/26) and AA2383 (expiring 9/30/26). The product was distributed to medical facilities in Mississippi and Florida.
Severe thunderstorms on April 2, 2025, caused shipping delays. Affected shipments were not delivered within the required 48-hour window, arriving instead on April 7 and 8, 2025. These delays may have caused the products to be stored outside the manufacturer's recommended temperature range.
Because storage conditions may not have met label specifications, the safety, quality, identity, potency, and purity of the affected lots may be compromised. This is an FDA Class II recall.
The recalled product
- Product
- INFUVITE ADULT (MULTIPLE VITAMINS INJECTION)
- Brand
- INFUVITE ADULT
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Injectable Vitamins
- Hazard
- temperature-excursion
- potency-loss
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: AA2279
- Exp 8/31/26
- AA2383
- Exp 9/30/26
Distribution
Distributed in 2 states:
- FL
- MS
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27